Efficacy of vagus nerve stimulation in the treatment of depression

References

• American Psychiatric Association, Task Force on DSM IV. Diagnostic and Statistical Manual of Mental Disorders – Text Revision (DSM IVTR) (4th Edition). American Psychiatric Association, Washington, DC, USA, 345–429 (2002).
   Google Scholar
• Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes study. JAMA262, 914–919 (1989).
   PubMed Web of Science ®Google Scholar
• Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry60(Suppl. 2), 57–62 (1999).
   PubMed Web of Science ®Google Scholar
• Rich CL, Young D, Fowler RC. San Diego suicide study. I. Young vs old subjects. Arch. Gen. Psychiatry43(6), 577–582 (1986).
   PubMed Web of Science ®Google Scholar
• Arató M, Demeter E, Rihmer Z, Somogyi E. Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr. Scand.77(4), 454–456 (1988).
   PubMed Web of Science ®Google Scholar
• Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Compr. Psychiatry1, 349–359 (1960).
   PubMed Web of Science ®Google Scholar
• Foster T, Gillespie K, McClelland R, Patterson C. Risk factors for suicide independent of DSM-III-R Axis I disorder. Case–control psychological autopsy study in Northern Ireland. Br. J. Psychiatry175, 175–179 (1999).
   PubMed Web of Science ®Google Scholar
• Henriksson MM, Aro HM, Marttunen MJ et al. Mental disorders and comorbidity in suicide. Am. J. Psychiatry150(6), 935–934 (1993).
   PubMed Web of Science ®Google Scholar
• Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. JAMA272. 1741–1748 (1994).
   PubMed Web of Science ®Google Scholar
• Kessler R, Barber C, Birnbaum H et al. Depression in the workplace: Effects on short-term disability. Health Affairs18, 163–171 (1999).
   PubMed Web of Science ®Google Scholar
• Fava M, Davidson K, Definition and epidemiology of treatment-resistant depression. Psychiatric Clin. N. Am.19, 179–200 (1996).
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron34, 13–25 (2002).
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E. Modern management of epilepsy: vagus nerve stimulation. Baillieres Clin. Neurol.5, 841–848 (1996).
   PubMedGoogle Scholar
• Landy HJ, Ramsay RE, Slater J, Casiano RR, Morgan R. Vagus nerve stimulation for complex partial seizures: surgical technique, safety, and efficacy. J. Neurosurg.78, 26–31 (1993).
   PubMedGoogle Scholar
• Rush AJ, Siefert SE. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp. Neurol.219(1), 36–43 (2009).
   PubMed Web of Science ®Google Scholar
• Vonck K, De Herdt V, Boon P. Vagal nerve stimulation – a 15-year survey of an established treatment modality in epilepsy surgery. Adv. Tech. Stand. Neurosurg.34, 111–146 (2009).
   PubMedGoogle Scholar
• George MS, Sackeim HA, Rush AJ et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry47, 287–295 (2000).
   PubMed Web of Science ®Google Scholar
• Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res.42, 203–210 (2000).
   PubMed Web of Science ®Google Scholar
• Sackeim HA, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology25, 713–728 (2001).
   PubMed Web of Science ®Google Scholar
• Rush AJ, Marangell LB, Sackeim HA et al. Vagus nerve stimulation for treatment-resistant depression: a randomised, controlled acute phase trial. Biol. Psychiatry58, 347–354 (2005).
   PubMed Web of Science ®Google Scholar
• Rush AJ, Sackeim HA, Marangell LB et al. Effects of 12 month vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol. Psychiatry58, 355–363 (2005).
   PubMed Web of Science ®Google Scholar
• George MS, Rush AJ, Marangell LB et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry58, 364–373 (2005).
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry64(6), 455–460 (2008).
   PubMed Web of Science ®Google Scholar
• Zahas Z, Marangell LB, Husain MM et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry66, 1097–1104 (2005).
   PubMedGoogle Scholar
• Carpenter LL, Moreno FA, Kling MA et al. Effects of vagus nerve stimulation on cerebrospinal fluid monoamine acid concentrations in depressed patients. Biol. Psychiatry56, 418–426 (2004).
   PubMed Web of Science ®Google Scholar
• Hammond EJ, Uthman BM, Reid SA, Wilder BJ. Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentials. Epilepsia33, 1021–1028 (1992).
   PubMedGoogle Scholar
• Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res.20, 221–227 (1995).
   PubMed Web of Science ®Google Scholar
• Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia39, 709–714 (1998).
   PubMed Web of Science ®Google Scholar
• Mu Q, Bohning DE, Nahas Z et al. Acute vagus nerve stimulation using different pulse width produces varying brain effects. Biol. Psychiatry55, 816–825 (2004).
   PubMed Web of Science ®Google Scholar
• Chae JH, Nahas Z, Lomarev M et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J. Psychiatric. Res.37, 443–455 (2003).
   PubMed Web of Science ®Google Scholar
• Henry TR. Therapeutic mechanism of vagus nerve stimulation. Neurology59, 3–14 (2002).
   PubMed Web of Science ®Google Scholar
• Smith B, Shatz R, Elisevich K, Bespalova IN, Burmeister M. Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type. Epilepsia41, 1046–1048 (2000).
   PubMed Web of Science ®Google Scholar
• Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry50, 171–178 (2001).
   PubMed Web of Science ®Google Scholar
• Nahas Z, Teneback C, Chae JH et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology32, 1649–1660 (2007).
   PubMed Web of Science ®Google Scholar
• Henry TR, Bakay RAE, Votaw JR et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia39, 983–990 (1998).
   PubMed Web of Science ®Google Scholar
• Mayberg HS, Brannan SK, Mahurin RK et al. Cingulate function in depression: a potential predictor of treatment response. Neuro. Report8, 1057–1061 (1997).
   PubMed Web of Science ®Google Scholar
• Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE. Effect of sleep deprivation on brain metabolism of depressed patients. Am. J. Psychiatry149, 538–543 (1992).
   PubMed Web of Science ®Google Scholar
• Ebert D, Feistel H, Kaschka W, Barocka A, Pimer A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation – preliminary results. Biol. Psychiatry35, 880–885 (1994).
   PubMed Web of Science ®Google Scholar
• Münchau A, Bloem BR, Irlbacher K, Trimble MR, Rothwell JC. Functional connectivity of human premotor and motor cortex explored with repetitive transcranial magnetic stimulation. J. Neurosci.22, 554–561 (2002).
   PubMed Web of Science ®Google Scholar
• Herwig U, Bräuer K, Connemann B, Spitzer M, Schönfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl.)164, 228–232 (2002).
   PubMed Web of Science ®Google Scholar
• Manganotti P, Bortolomasi M, Zanette G, Pawelzik T, Giacopuzzi M, Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J. Neurol. Sci.184, 27–32 (2001).
   PubMedGoogle Scholar
• Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J. Psychiatr. Res.40, 322–327 (2005).
   PubMedGoogle Scholar
• Bajbouj M, Brakemeier EL, Schubert F et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder. Exp. Neurol.196, 332–338 (2005).
   PubMedGoogle Scholar
• Bajbouj M, Gallinat J, Lang UE et al. Motor cortex excitability after vagus nerve stimulation in major depression. J. Clin. Psychopharmacol.27, 156–159 (2007).
   PubMedGoogle Scholar
• Di Lazzaro V, Oliviero A, Pilato F et al. Effects of vagus nerve stimulation on cortical excitability in epileptic patients. Neurology62, 2310–2312 (2004).
   PubMedGoogle Scholar
• Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp. Brain Res.109, 127–135 (1996).
   PubMed Web of Science ®Google Scholar
• Hanajima R, Ugawa Y, Terao Y et al. Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J. Physiol.509(Pt 2), 607–618 (1998).
   PubMed Web of Science ®Google Scholar
• Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J. Physiol.530, 307–317 (2001).
   PubMed Web of Science ®Google Scholar
• Sanacora G, Mason GF, Rothman DL et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry160, 577–579 (2003).
   PubMed Web of Science ®Google Scholar
• Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry159, 663–665 (2002).
   PubMed Web of Science ®Google Scholar
• Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry59, 395–400 (2006).
   PubMedGoogle Scholar
• Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J. ECT15, 5–26 (1999).
   PubMedGoogle Scholar
• Bajbouj M, Gallinat J, Lang UE et al. Motor cortex excitability after vagus nerve stimulation in major depression. J. Clin. Psychopharmacol.27, 156–159 (2007).
   PubMedGoogle Scholar
• Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia40, 1051–1057 (1999).
   PubMedGoogle Scholar
• Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev.31(6), 858–873 (2007).
   PubMed Web of Science ®Google Scholar